[[renal_cell_cancer]]

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
renal_cell_cancer [2019/07/09 23:20]
Graham Grove
renal_cell_cancer [2019/07/09 23:23] (current)
Graham Grove
Line 33: Line 33:
 Certain histological sub-types of renal cell cancer are associated with a poor prognosis too. Patients with sarcomatoid features generally have a poorer prognosis. In one study, approximately 20% of patients with this cancer had a partial response to treatment, 50% had a stable disease and 30% had progressive disease, with a overall median survival of 5 months.[(​​Golshayan et al. Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy. Clin Oncol. 2009; 27(2):​235.)] Certain histological sub-types of renal cell cancer are associated with a poor prognosis too. Patients with sarcomatoid features generally have a poorer prognosis. In one study, approximately 20% of patients with this cancer had a partial response to treatment, 50% had a stable disease and 30% had progressive disease, with a overall median survival of 5 months.[(​​Golshayan et al. Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy. Clin Oncol. 2009; 27(2):​235.)]
  
-{{tag>​condition oncology urology kidney}}+{{tag>​condition oncology urology kidney ​textbook}}
  
  • renal_cell_cancer.txt
  • Last modified: 2019/07/09 23:23
  • by Graham Grove